P. Sharp

1.8k total citations
40 papers, 1.5k citations indexed

About

P. Sharp is a scholar working on Molecular Biology, Physiology and Clinical Biochemistry. According to data from OpenAlex, P. Sharp has authored 40 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 20 papers in Physiology and 17 papers in Clinical Biochemistry. Recurrent topics in P. Sharp's work include Peroxisome Proliferator-Activated Receptors (27 papers), Metabolism and Genetic Disorders (17 papers) and Adipose Tissue and Metabolism (10 papers). P. Sharp is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (27 papers), Metabolism and Genetic Disorders (17 papers) and Adipose Tissue and Metabolism (10 papers). P. Sharp collaborates with scholars based in Australia, United States and Canada. P. Sharp's co-authors include A. Poulos, David W. Johnson, A.J. Fellenberg, Harmeet Singh, M.J. Whiting, Peter J. Meikle, Phillip D. Whitfield, Barbara C. Paton, Christopher J. Easton and Denis I. Crane and has published in prestigious journals such as Journal of Clinical Investigation, Molecular and Cellular Biology and Neurology.

In The Last Decade

P. Sharp

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Sharp Australia 25 1.0k 522 488 193 163 40 1.5k
Richard Bucala United States 17 728 0.7× 384 0.7× 1.3k 2.6× 86 0.4× 88 0.5× 21 2.3k
Jean‐François Decaux France 23 981 1.0× 364 0.7× 190 0.4× 139 0.7× 97 0.6× 44 1.7k
R. J. A. Wanders Netherlands 16 1.3k 1.2× 257 0.5× 505 1.0× 138 0.7× 33 0.2× 34 1.4k
Audrey Boutron France 21 1.2k 1.1× 228 0.4× 627 1.3× 230 1.2× 42 0.3× 47 1.6k
Akira Ohtake Japan 27 1.9k 1.9× 226 0.4× 1.1k 2.4× 146 0.8× 63 0.4× 138 2.7k
Deborah Carper United States 26 1.2k 1.2× 386 0.7× 241 0.5× 206 1.1× 277 1.7× 61 2.4k
James B. Blair United States 20 711 0.7× 340 0.7× 177 0.4× 140 0.7× 40 0.2× 42 1.3k
Matilde S. Ayuso Spain 23 704 0.7× 312 0.6× 123 0.3× 98 0.5× 48 0.3× 94 1.4k
Al‐Walid Mohsen United States 24 1.3k 1.3× 361 0.7× 831 1.7× 95 0.5× 32 0.2× 67 1.9k
Joyce E. Becker United States 17 605 0.6× 215 0.4× 196 0.4× 249 1.3× 125 0.8× 23 1.4k

Countries citing papers authored by P. Sharp

Since Specialization
Citations

This map shows the geographic impact of P. Sharp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Sharp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Sharp more than expected).

Fields of papers citing papers by P. Sharp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Sharp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Sharp. The network helps show where P. Sharp may publish in the future.

Co-authorship network of co-authors of P. Sharp

This figure shows the co-authorship network connecting the top 25 collaborators of P. Sharp. A scholar is included among the top collaborators of P. Sharp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Sharp. P. Sharp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Derrick‐Roberts, Ainslie L.K., Xenia Kaidonis, Matilda R. Jackson, et al.. (2020). Comparative analysis of brain pathology in heparan sulphate storing mucopolysaccharidoses. Molecular Genetics and Metabolism. 131(1-2). 197–205. 3 indexed citations
2.
Simpson, Andrew, et al.. (2019). Effect of Creatine Supplementation on the Airways of Youth Elite Soccer Players. Medicine & Science in Sports & Exercise. 51(8). 1582–1590. 10 indexed citations
3.
Kaidonis, Xenia, Sharon Byers, Enzo Ranieri, et al.. (2016). N-butyldeoxynojirimycin treatment restores the innate fear response and improves learning in mucopolysaccharidosis IIIA mice. Molecular Genetics and Metabolism. 118(2). 100–110. 9 indexed citations
4.
Fuller, Maria, P. Sharp, Tina Rozaklis, et al.. (2005). Urinary Lipid Profiling for the Identification of Fabry Hemizygotes and Heterozygotes. Clinical Chemistry. 51(4). 688–694. 48 indexed citations
5.
Whitfield, Phillip D., Paul V. Nelson, P. Sharp, et al.. (2002). Correlation among Genotype, Phenotype, and Biochemical Markers in Gaucher Disease: Implications for the Prediction of Disease Severity. Molecular Genetics and Metabolism. 75(1). 46–55. 43 indexed citations
6.
Paton, Barbara C., et al.. (2002). Molecular analysis of genomic DNA allows rapid, and accurate, prenatal diagnosis of peroxisomal D‐bifunctional protein deficiency. Prenatal Diagnosis. 22(1). 38–41. 4 indexed citations
7.
Whitfield, Phillip D., et al.. (2001). Characterization of Urinary Sulfatides in Metachromatic Leukodystrophy Using Electrospray Ionization-Tandem Mass Spectrometry. Molecular Genetics and Metabolism. 73(1). 30–37. 41 indexed citations
8.
Jones, M. Z., Joseph Alroy, Philip J. Boyer, et al.. (1998). Caprine Mucopolysaccharidosis-IIID. Journal of Neuropathology & Experimental Neurology. 57(2). 148–157. 30 indexed citations
9.
Sharp, P., Eric Haan, Janice M. Fletcher, T. Yee Khong, & W.F. Carey. (1997). FIRST-TRIMESTER DIAGNOSIS OF SMITH–LEMLI–OPITZ SYNDROME. Prenatal Diagnosis. 17(4). 355–361. 30 indexed citations
10.
Paton, Barbara C., P. Sharp, Denis I. Crane, & A. Poulos. (1996). Oxidation of pristanic acid in fibroblasts and its application to the diagnosis of peroxisomal beta-oxidation defects.. Journal of Clinical Investigation. 97(3). 681–688. 25 indexed citations
11.
Gibson, Robert A., et al.. (1994). Very long chain fatty acids in X‐linked adrenoleukodystrophy brain after treatment with Lorenzo's oil. Annals of Neurology. 36(5). 741–746. 56 indexed citations
12.
Carey, W.F., et al.. (1994). Pitfalls in the prenatal diagnosis of peroxisomal β‐oxidation defects by chorionic villus sampling. Prenatal Diagnosis. 14(9). 813–819. 14 indexed citations
13.
Poulos, A., K. Beckman, David W. Johnson, et al.. (1992). Very Long-Chain Fatty Acids in Peroxisomal Disease. Advances in experimental medicine and biology. 318. 331–340. 20 indexed citations
14.
15.
Poulos, A., Alan T. Bankier, K. Beckman, et al.. (1991). Glyceryl ethers in peroxisomal disease. Clinical Genetics. 39(1). 13–25. 10 indexed citations
16.
Robertson, E. F., et al.. (1988). Treatment of infantile phytanic acid storage disease: clinical, biochemical and ultrastructural findings in two children treated for 2 years. European Journal of Pediatrics. 147(2). 133–142. 24 indexed citations
17.
Poulos, A., L. J. Sheffield, P. Sharp, et al.. (1988). Rhizomelic chondrodysplasia punctata: Clinical, pathologic, and biochemical findings in two patients. The Journal of Pediatrics. 113(4). 685–690. 47 indexed citations
18.
Poulos, A., P. Sharp, A.J. Fellenberg, & David W. Johnson. (1988). Accumulation of pristanic acid (2, 6, 10, 14 tetramethylpentadecanoic acid) in the plasma of patients with generalised peroxisomal dysfunction. European Journal of Pediatrics. 147(2). 143–147. 63 indexed citations
19.
Poulos, A., P. Sharp, A.J. Fellenberg, & David M. Danks. (1985). Cerebro-hepato-renal (Zellweger) syndrome, adrenoleukodystrophy, and Refsum's disease: Plasma changes and skin fibroblast phytanic acid oxidase. Human Genetics. 70(2). 172–177. 57 indexed citations
20.
Sharp, P.. (1982). Lassa fever in children. Journal of Infection. 4(1). 73–77. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Bucala Breakdown of academic impact, for papers by Jean‐François Decaux Breakdown of academic impact, for papers by R. J. A. Wanders Breakdown of academic impact, for papers by Audrey Boutron Breakdown of academic impact, for papers by Akira Ohtake Breakdown of academic impact, for papers by Deborah Carper Breakdown of academic impact, for papers by James B. Blair Breakdown of academic impact, for papers by Matilde S. Ayuso Breakdown of academic impact, for papers by Al‐Walid Mohsen Breakdown of academic impact, for papers by Joyce E. Becker
Rankless by CCL
2026